Document is current
Any future updates will be listed below
-
Authors
Al-Hity, Gheed https://orcid.org/0000-0003-2011-0162
Yang, FengWei https://orcid.org/0000-0002-0619-0840
Campillo-Funollet, Eduard https://orcid.org/0000-0001-7021-1610
Greenstein, Andrew E. https://orcid.org/0000-0002-1470-1970
Hunt, Hazel https://orcid.org/0000-0002-4316-1301
Mampay, Myrthe https://orcid.org/0000-0002-4966-2721
Intabli, Haya https://orcid.org/0000-0003-3820-4431
Falcinelli, Marta https://orcid.org/0000-0001-6496-6953
Madzvamuse, Anotida https://orcid.org/0000-0002-9511-8903
Venkataraman, Chandrasekhar https://orcid.org/0000-0003-4039-2056
Flint, Melanie S. https://orcid.org/0000-0001-5311-3023
- License Information
-
More Information
Article History
Received: 1 October 2020
Accepted: 3 June 2021
First Online: 24 June 2021
Competing interests
: All authors have no competing interest, except that Hazel Hunt and Andrew Greenstein are both Corcept stockholders.
: The experiments involving animals and Schedule 1 protocols used to obtain breast tumour tissue were approved by the Animal Welfare and Ethical Review Body (AWERB committee) of the University of Brighton. This study was conducted in accordance with the principles of the Basel Declaration and adhered to the legislation detailed in the United Kingdom Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039). All efforts were taken to maximise animal welfare conditions and to reduce the number of animals used in accordance with the European Communities Council Directive of September 20th, 2010 (2010/63/EU).
